ATXI Avenue Therapeutics, Inc.
Fundamentals / CIK 0001644963 / USDAvenue Therapeutics, Inc. reported $1.40M in revenue and a net loss of $2.79M for the fiscal year ended December 31, 2025, with a -204.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATXI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$1.40M Dec 31, 2025
-
Operating Income FY 2025-$2.88M -204.9% margin
-
Net Income FY 2025-$2.79M -198.4% net margin
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$1.52M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $1.04M | $6.64M | $6.13M | $2.70M | $1.25M | $2.87M | $22.19M | $17.70M | $6.70M | $1.33M |
| Total Operating Expenses | $4.49M | $11.28M | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Income | -$3.08M | -$11.28M | -$14.54M | -$8.04M | -$3.74M | -$5.21M | -$26.27M | -$21.82M | -$11.42M | -$2.38M |
| Interest Income | $121K | $176K | $126K | $20K | $7.0K | $62K | $357K | $93K | $88K | $0 |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 | $294K | $420K |
| Income Tax Expense | $2.0K | $0 | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Net Income | -$2.91M | -$11.65M | -$10.38M | -$3.55M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M |
| Basic EPS | -$0.93 | -$15.79 | -$73.48 | -$1.63 | -$0.22 | -$0.31 | -$1.65 | -$2.11 | -$1.85 | -$1.11 |
| Diluted EPS | -- | -- | -- | -- | -$0.22 | -$0.31 | -$1.65 | -$2.11 | -$1.85 | -$1.11 |
| Basic Shares Outstanding | 3.1M | 1.3M | 141.2K | 2.2M | 1.1M | 16.5M | 15.7M | 10.2M | 6.6M | 2.9M |
| Diluted Shares Outstanding | -- | -- | -- | 2.2M | 1.1M | 16.5M | 15.7M | 10.2M | 6.6M | 2.9M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | -- | -- | $0 | $1.40M | -- | -- |
| Research & Development | $212K | $247K | $200K | $257K | $177K | $192K | $411K | $565K |
| Total Operating Expenses | $704K | $707K | -- | -- | $724K | $1.11M | -- | -- |
| Operating Income | -$704K | -$707K | -$714K | -$752K | -$724K | $297K | -$1.91M | -$1.60M |
| Interest Income | $13K | $17K | $18K | $25K | $34K | $31K | $32K | $24K |
| Net Income | -$691K | -$690K | -$695K | -$709K | -$683K | $335K | -$1.85M | -$1.54M |
| Basic EPS | -$0.20 | -$0.21 | -$0.21 | -- | -$0.21 | $0.11 | -$0.62 | -- |
| Basic Shares Outstanding | 3.5M | 3.3M | 3.3M | -- | 3.2M | 3.2M | 3.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $11.78M | $197K |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 | $10.00M | $0 |
| Cash & Short-Term Investments | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $21.78M | $197K |
| Total Current Assets | -- | -- | -- | -- | $3.96M | $3.25M | -- | -- | -- | -- |
| Total Non-Current Assets | -- | -- | -- | -- | $0 | $0 | -- | -- | -- | -- |
| Total Assets | $2.93M | $2.67M | $1.85M | $6.84M | $3.96M | $3.25M | $8.91M | $4.53M | $22.17M | $197K |
| Accounts Payable | -- | $155K | $78K | $129K | $304K | $143K | $354K | $3.09M | $1.54M | $334K |
| Total Current Liabilities | $1.10M | $816K | $1.20M | $3.58M | $509K | $886K | $2.12M | $5.16M | $2.79M | $6.42M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.03M |
| Total Liabilities | $1.10M | $816K | $1.20M | $3.58M | $509K | $886K | $2.12M | $5.16M | $2.79M | $8.45M |
| Common Stock | $0 | $0 | $3.0K | $0 | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$105.5M | -$102.6M | -$90.93M | -$80.55M | -$77.00M | -$73.27M | -$68.12M | -$42.21M | -$20.66M | -$8.40M |
| Total Stockholders' Equity | $1.83M | $2.80M | $1.58M | $3.90M | $3.45M | $2.36M | $6.80M | -$631K | $19.38M | -$8.25M |
| Total Equity | $1.83M | $1.86M | $654K | $3.27M | $3.45M | $2.36M | $6.80M | -$631K | $19.38M | -$8.25M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.52M | $1.94M | $2.42M | $2.85M | $3.71M | $3.33M | $3.50M | $2.59M |
| Cash & Short-Term Investments | $1.52M | $1.94M | $2.42M | $2.85M | $3.71M | $3.33M | $3.50M | $2.59M |
| Total Assets | $1.53M | $1.98M | $2.47M | $2.93M | $3.73M | $4.16M | $3.59M | $2.67M |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | $155K |
| Total Current Liabilities | $1.60M | $1.41M | $1.27M | $1.10M | $1.42M | $1.33M | $1.26M | $816K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.60M | $1.41M | $1.27M | $1.10M | $1.42M | $1.33M | $1.26M | $816K |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$107.6M | -$106.9M | -$106.2M | -$105.5M | -$104.8M | -$104.1M | -$104.4M | -$102.6M |
| Total Stockholders' Equity | -$75K | $569K | $1.20M | $1.83M | $3.56M | $4.06M | $3.51M | $2.80M |
| Total Equity | -$75K | $569K | $1.20M | $1.83M | $2.30M | $2.83M | $2.33M | $1.86M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.95M | -$11.70M | -$10.49M | -$3.60M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M |
| Stock-Based Compensation | $665K | $1.24M | $906K | $649K | $442K | $710K | $1.84M | $1.54M | $604K | $28K |
| Operating Cash Flow | -$1.83M | -$9.03M | -$9.45M | -$7.60M | -$3.75M | -$4.61M | -$26.26M | -$18.22M | -$6.80M | -$1.63M |
| Purchases of Investments | -- | -- | -- | -- | -- | $0 | -$5.00M | $0 | -$10.00M | $0 |
| Investing Cash Flow | -- | $0 | -$3.00M | $0 | -- | -$1.00M | $0 | $10.00M | -$10.00M | $0 |
| Common Stock Issued | $2.09M | $1.62M | $0 | -- | $5.04M | $0 | $35.00M | $0 | $37.95M | $0 |
| Share Repurchases | -- | -- | $0 | -$1.10M | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $2.09M | $9.84M | $7.53M | $10.54M | $4.38M | $0 | $32.33M | -$895K | $28.39M | $1.81M |
| Net Change in Cash | $261K | $811K | -$4.92M | $2.94M | $631K | -$5.61M | $6.07M | -$9.11M | -- | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$691K | -$690K | -$695K | -$726K | -$692K | $329K | -$1.86M | -$1.56M |
| Stock-Based Compensation | $47K | $61K | $61K | $142K | $163K | $175K | $185K | $522K |
| Operating Cash Flow | -$422K | -$475K | -$438K | -$854K | $383K | -$176K | -$1.19M | -$764K |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $0 | $2.09M | $761K |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $2.09M | $761K |
| Net Change in Cash | -$422K | -$475K | -$438K | -$854K | $383K | -$176K | $908K | -$3.0K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -219.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Profit Margin | -207.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -158.8% | -416.6% | -655.9% | -91.0% | -108.1% | -218.4% | -381.0% | -- | -63.3% | -- |
| Return on Assets (ROA) | -99.2% | -436.1% | -560.9% | -51.9% | -94.2% | -158.7% | -290.6% | -476.2% | -55.3% | -1612.7% |
| Current Ratio | -- | -- | -- | -- | 7.78x | 3.66x | -- | -- | -- | -- |
| Quick Ratio | 2.60x | 3.18x | 1.49x | 1.87x | 7.39x | 3.53x | 4.13x | 0.52x | 7.81x | 0.03x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -488.0% | -146.2% | -158.8% | -105.3% | -151.2% | -261.1% | -416.6% |
| Return on Assets (ROA) | -182.0% | -140.5% | -71.0% | -99.2% | -100.5% | -147.5% | -255.0% | -436.1% |
| Quick Ratio | 0.95x | 1.38x | 1.90x | 2.60x | 2.61x | 2.50x | 2.77x | 3.18x |
| Revenue Growth (YoY) | -- | -100.0% | -- | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -338.0% | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -306.0% | -- | -- | -- | -- | -- | -341.2% |
| EPS Growth (YoY) | -- | -290.9% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -210.2% | -- | -- | -- | -- | -- | -- | -- |